Cite
Inflammatory and Tissue Damage Biomarkers Progression as Mortality Prognosis in Patients with Covid-19 Disease
MLA
Monica Escamilla Tilch, et al. “Inflammatory and Tissue Damage Biomarkers Progression as Mortality Prognosis in Patients with Covid-19 Disease.” Journal of Cardio-Thoracic Medicine, vol. 9, no. 4, Dec. 2021, pp. 878–83. EBSCOhost, https://doi.org/10.22038/jctm.2021.60678.1354.
APA
Monica Escamilla Tilch, Lourdes López Dawn, Adriana Balderrama, Francisco Ramírez Bernal, Brigney Aceves Poveda, Guillermo Díaz Quiroz, Alberto De la Vega, Paul Mondragón-Terán, & José Aceves Chimal. (2021). Inflammatory and Tissue Damage Biomarkers Progression as Mortality Prognosis in Patients with Covid-19 Disease. Journal of Cardio-Thoracic Medicine, 9(4), 878–883. https://doi.org/10.22038/jctm.2021.60678.1354
Chicago
Monica Escamilla Tilch, Lourdes López Dawn, Adriana Balderrama, Francisco Ramírez Bernal, Brigney Aceves Poveda, Guillermo Díaz Quiroz, Alberto De la Vega, Paul Mondragón-Terán, and José Aceves Chimal. 2021. “Inflammatory and Tissue Damage Biomarkers Progression as Mortality Prognosis in Patients with Covid-19 Disease.” Journal of Cardio-Thoracic Medicine 9 (4): 878–83. doi:10.22038/jctm.2021.60678.1354.